[HIV-1 integrase inhibitor resistance among treatment naïve patients in Gran Canaria, 2017].
作者信息
Pena López M J, Hernández Febles M, Medina Galindo J A, Pérez Jiménez R D
机构信息
María José Pena López, Hospital Universitario de Gran Canaria Dr. Negrín, Servicio de Microbiología c/Barranco de la Ballena s/n, 35019- Las Palmas de Gran Canaria.
出版信息
Rev Esp Quimioter. 2018 Oct;31(5):459-460. Epub 2018 Sep 17.
Abstract
摘要
相似文献
1
[HIV-1 integrase inhibitor resistance among treatment naïve patients in Gran Canaria, 2017].[2017年大加那利岛初治患者中HIV-1整合酶抑制剂耐药情况]
Rev Esp Quimioter. 2018 Oct;31(5):459-460. Epub 2018 Sep 17.
2
Novel integrase inhibitors for HIV.新型 HIV 整合酶抑制剂。
Expert Opin Investig Drugs. 2010 Sep;19(9):1087-98. doi: 10.1517/13543784.2010.501078.
3
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation.超深度测序检测R263K整合酶抑制剂耐药突变
J Antimicrob Chemother. 2017 May 1;72(5):1537-1539. doi: 10.1093/jac/dkw571.
4
Two cases of dolutegravir failure with R263K mutation.两例因R263K突变导致多替拉韦治疗失败的病例。
AIDS. 2018 Nov 13;32(17):2639-2640. doi: 10.1097/QAD.0000000000001978.
5
Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada.加拿大对HIV-1整合酶抑制剂的原发性耐药率
J Acquir Immune Defic Syndr. 2018 May 1;78(1):e1-e3. doi: 10.1097/QAI.0000000000001649.
6
Resistance to HIV-1 integrase inhibitors: A structural perspective.HIV-1 整合酶抑制剂耐药性：结构视角。
Drug Resist Updat. 2010 Aug-Oct;13(4-5):139-50. doi: 10.1016/j.drup.2010.05.001. Epub 2010 Jun 8.
7
Characterization and structural analysis of HIV-1 integrase conservation.HIV-1整合酶保守性的表征与结构分析
AIDS Rev. 2009 Jan-Mar;11(1):17-29.
8
Primary resistance to integrase strand-transfer inhibitors in Europe.欧洲对整合酶链转移抑制剂的原发性耐药性。
J Antimicrob Chemother. 2015 Oct;70(10):2885-8. doi: 10.1093/jac/dkv202. Epub 2015 Jul 17.
9
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients.拉替拉韦初治和经治患者中与多替拉韦耐药相关的 HIV-1 整合酶突变的流行率。
Clin Microbiol Infect. 2012 Oct;18(10):E428-30. doi: 10.1111/j.1469-0691.2012.03917.x. Epub 2012 Jun 21.
10
Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand Transfer Inhibitor Resistance.HIV-1 3'-多聚嘌呤序列突变与整合酶链转移抑制剂耐药性
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02432-20.
本文引用的文献
1
Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017).西班牙艾滋病研究与治疗协作组/国家艾滋病计划关于人类免疫缺陷病毒感染成人抗逆转录病毒治疗的共识文件执行摘要（2017年1月更新）
Enferm Infecc Microbiol Clin (Engl Ed). 2018 Aug-Sep;36(7):435-445. doi: 10.1016/j.eimc.2017.04.001. Epub 2017 Jun 1.
2
HIV-1 integrase inhibitor resistance among treatment naïve patients in the West of Scotland.苏格兰西部初治患者中的 HIV-1 整合酶抑制剂耐药情况。
J Clin Virol. 2017 Jul;92:7-10. doi: 10.1016/j.jcv.2017.04.012. Epub 2017 Apr 23.
3
Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials.HIV-1患者中对整合酶链转移抑制剂出现的治疗性耐药：临床试验的亚组荟萃分析
PLoS One. 2016 Aug 17;11(8):e0160087. doi: 10.1371/journal.pone.0160087. eCollection 2016.
4
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.瑞士HIV队列研究中成功预防整合酶耐药性的传播
J Infect Dis. 2016 Aug 1;214(3):399-402. doi: 10.1093/infdis/jiw165. Epub 2016 Apr 29.
5
Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan.台湾地区接受自愿咨询检测的个体中HIV-1毒株的传播性耐药情况。
J Antimicrob Chemother. 2016 Jan;71(1):226-34. doi: 10.1093/jac/dkv284. Epub 2015 Sep 23.
6
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades.初治及曾接受拉替拉韦治疗的、感染多种HIV-1进化枝的患者中整合酶抑制剂（INI）的基因型耐药情况。
J Antimicrob Chemother. 2015 Nov;70(11):3080-6. doi: 10.1093/jac/dkv243. Epub 2015 Aug 26.
7
Primary resistance to integrase strand-transfer inhibitors in Europe.欧洲对整合酶链转移抑制剂的原发性耐药性。
J Antimicrob Chemother. 2015 Oct;70(10):2885-8. doi: 10.1093/jac/dkv202. Epub 2015 Jul 17.
8
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.502例raltegravir治疗失败患者对elvitegravir和dolutegravir的交叉耐药性：一项针对有raltegravir治疗经验的HIV-1感染患者的法国全国性研究。
J Antimicrob Chemother. 2015 May;70(5):1507-12. doi: 10.1093/jac/dku535. Epub 2015 Jan 3.
9
Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient.一名感染HIV-1 CRF_AG的患者中出现的雷特格韦耐药性传播情况。
Antivir Ther. 2011;16(2):257-61. doi: 10.3851/IMP1749.
10
Transmission of integrase strand-transfer inhibitor multidrug-resistant HIV-1: case report and response to raltegravir-containing antiretroviral therapy.整合酶链转移抑制剂耐药的HIV-1传播：病例报告及对含raltegravir抗逆转录病毒疗法的反应
Antivir Ther. 2011;16(2):253-6. doi: 10.3851/IMP1748.
Zotero 插件